EUVIMEDEUVIMED entdecken
Übersichtsarbeit

A review on assessment of advances in polymers and their hybrid nanosystem for leukaemia theranostics applications

Soni Prajapati iD, Akash Kumar iD, Ranjana Singh iD

Biomedical Materials · 01.08.2026 · 21 (4) · 042004

DOI: 10.1088/1748-605x/ae83f7 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomedical Materials, online erschienen am 24.07.2026. Verfasst von Soni Prajapati und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, King George's Medical University, Lucknow, India. Hauptthemen laut MEDLINE: Polymers, Theranostic Nanomedicine, Leukemia, Nanoparticles. Die Arbeit nennt 236 Literaturangaben. Gefördert von: ICMR-DHR.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Leukaemia, a widespread haematological cancer, possesses particular challenges in theranostics despite the availability of traditional and modern approaches. This article addresses a significant gap in the literature: a lack of focus on polymeric and hybrid nanoparticles (P&HNP) in advancing leukaemia therapy. It explores how to overcome limitations of conventional therapeutic approaches. The rationale for this study stems from several considerations, including the fact that while polymeric nanoparticles show promise in leukaemia theranostics, a comprehensive assessment of how biomaterial choices influence therapeutic efficacy remains lacking. This article briefly describes conventional challenges in leukaemia theranostics, followed by the properties of P&HNP that make them potential candidates for leukaemia management. In addition, an understanding of the distinctions between natural (e.g. chitosan) and synthetic polymers (e.g. polyethene glycol), as well as their capacity to integrate targeting ligands, imaging agents, and therapeutic payloads, is essential for the rational design of next-generation treatments. Indeed, hybrid nanosystems that combine polymers with metallic nanoparticles (e.g. Au, Ag, Fe, and Zn) represent an emerging frontier, as noted. Next, the current status and clinical outcomes of P&HNP-based formulations are presented, along with their limitations and solutions to advance them as advanced therapies. Finally, challenges or obstacles that limit the translation perspective of laboratory-designed nanomedicine were addressed. This review identifies promising directions, including innovative nanoparticle designs and combination therapies, that may transform leukaemia treatment paradigms and improve patient survival.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PolymersTheranostic NanomedicineLeukemiaNanoparticlesHumansAnimalsBiocompatible MaterialsAntineoplastic Agents

Stichwörter der Autor:innen

diagnosticsleukaemiananoparticlespolymer and hybridtherapeutics

Substanzen

PolymersBiocompatible MaterialsAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Biochemistry, King George's Medical University, Lucknow, India.
  • Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India.

ORCID-Profile: Soni Prajapati, Akash Kumar, Ranjana Singh

Förderung

  • ICMR-DHR

Zitieren

APA

Prajapati, S., Kumar, A., & Singh, R. (2026). A review on assessment of advances in polymers and their hybrid nanosystem for leukaemia theranostics applications. Biomedical Materials, 21(4), 042004. https://doi.org/10.1088/1748-605x/ae83f7

Vancouver

Prajapati S, Kumar A, Singh R. A review on assessment of advances in polymers and their hybrid nanosystem for leukaemia theranostics applications. Biomedical Materials. 2026;21(4):042004. doi:10.1088/1748-605x/ae83f7

BibTeX
@article{Prajapati2026,
  author = {Prajapati, Soni and Kumar, Akash and Singh, Ranjana},
  title = {A review on assessment of advances in polymers and their hybrid nanosystem for leukaemia theranostics applications},
  journal = {Biomedical Materials},
  year = {2026},
  volume = {21},
  number = {4},
  pages = {042004},
  doi = {10.1088/1748-605x/ae83f7}
}
Kostenlos starten →